A novel GLP1 receptor interacting protein ATP6ap2 regulates insulin secretion in pancreatic cells
Given that the Rehan 2024 case was reported in a conference abstract with incomplete data, the agent unspecified, and causality unverifiable by independent assessment, this event is characterised as a reported temporal association rather than a confirmed causal relationship
Patients were prescribed either the GLP-1 agonists liraglutide or semaglutide or other weight-loss drugs (OWLDs) including lorcaserin, sibutramine, setmelanotide, fenfluramine, mazindol, orlistat, phentermine and diethylpropion
Using bacteriostatic water rather than sterile saline extends the stability of the reconstituted solution to approximately 30 days under refrigeration
Also, make sure the injection site is clean before injecting